Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

December 01, 2025 11:42 ET | Source: MISTR

New Emory University Study Published in JAMA Confirms MISTR’s Telehealth Model is Transforming HIV Prevention in the U.S.

San Juan, PR, Dec. 01, 2025 (GLOBE NEWSWIRE) -- A new study from Emory University, published today in the Journal of the American Medical Association (JAMA), confirms that telehealth has become a...
November 10, 2025 10:25 ET | Source: ACTG

ACTG Presents SLIM LIVER Findings at AASLD Liver Meeting Demonstrating Improvements in Biomarkers of Cardiovascular Risk among People Living with HIV and MASLD Who Receive Semaglutide

Treating people living with HIV and metabolic dysfunction-associated MASLD with semaglutide significantly improved biomarkers of cardiovascular risk.
October 14, 2025 09:00 ET | Source: bioLytical Laboratories Inc.

HIV Self-Testing Just Got Faster: FDA Approves the 1-Minute INSTI® HIV Self Test

FDA approves INSTI® HIV Self Test, the first 1-minute at-home HIV test in the U.S., delivering accurate, private results to expand awareness.
October 10, 2025 10:46 ET | Source: MISTR

Dua Lipa, Drag Icons, Diplo and Celebrities Headline MISTR’s National PrEP Day Kickoff

West Hollywood, Ca, Oct. 10, 2025 (GLOBE NEWSWIRE) -- Last night, MISTR lit up The Abbey in West Hollywood to launch the inaugural National PrEP Day with a star-powered Blue Carpet Countdown event....
September 30, 2025 09:12 ET | Source: MISTR

MISTR & SISTR Launch First-Ever National PrEP Day to End HIV in America

Miami, FL, Sept. 30, 2025 (GLOBE NEWSWIRE) -- MISTR, the nation’s largest telehealth platform for sexual health, and its companion platform SISTR, are launching the first-ever National PrEP...
September 05, 2025 07:30 ET | Source: Theratechnologies

Theratechnologies annonce la disponibilité d’EGRIFTA WR (MC) (tésamoréline) pour injection pour la réduction de l’excès de graisse abdominale chez les adultes vivant avec le VIH atteints de lipodystrophie

EGRIFTA WRMC offre la commodité d’une reconstitution hebdomadaire et d’un volume d’injection quotidien réduit, comparativement à EGRIFTA SVMD Les pharmacies spécialisées commandent désormais...
September 05, 2025 07:30 ET | Source: Theratechnologies

Theratechnologies Announces Availability of EGRIFTA WR™ (tesamorelin) for injection to Reduce Excess Abdominal Fat in Adults with HIV and Lipodystrophy

EGRIFTA WR™ offers convenience of weekly reconstitution and reduced daily injection volume, compared to EGRIFTA SV® Specialty pharmacies are now ordering EGRIFTA WR™ to fill prescriptions MONTREAL,...
August 19, 2025 15:38 ET | Source: The Wistar Institute

The Wistar Institute Receives $17 Million NIH Grant for Personalized HIV Cure Research

Philadelphia, PA, Aug. 19, 2025 (GLOBE NEWSWIRE) -- The Wistar Institute announces the National Institutes of Health (NIH) granted a five-year, $17 million research award to launch iCure Consortium...
August 14, 2025 14:24 ET | Source: Istios Health

Istios Health Partners with Infectious Disease Consultants of Georgia to Advance Infectious Disease Research and Drug Development in the Southeast

PHOENIX, Aug. 14, 2025 (GLOBE NEWSWIRE) -- Istios Health, a healthcare technology company transforming infectious disease (ID) care through integrated clinical services, real-world data, and...
August 14, 2025 09:50 ET | Source: Research and Markets

HIV Diagnostics Company Evaluation Report 2025 | Abbott, Siemens Healthineers, and Thermo Fisher Scientific Lead the Market with Innovative Portfolios and Strategic Expansion

Dublin, Aug. 14, 2025 (GLOBE NEWSWIRE) -- The "HIV Diagnostics - Company Evaluation Report, 2025" report has been added to ResearchAndMarkets.com's offering.The HIV Diagnostics Companies Quadrant...